Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)
Posted On Wednesday, August 06, 2025
Cardurion Pharmaceuticals Completes Enrollment in Phase 2 CYCLE Trials Evaluating CRD-750, a Novel PDE9 inhibitor, in Heart Failure
Posted On Wednesday, August 06, 2025
NKGen Biotech To Present on Allogeneic Enhanced NK Cells without Lymphodepletion in Solid Tumors at the 13th Annual Immuno-Oncology Summit
Posted On Wednesday, August 06, 2025
4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Posted On Wednesday, August 06, 2025
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Posted On Wednesday, August 06, 2025
Glass House Brands to Host Second Quarter 2025 Conference Call on August 13, 2025
Posted On Wednesday, August 06, 2025
PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results
Posted On Wednesday, August 06, 2025
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
Posted On Wednesday, August 06, 2025
Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
Posted On Tuesday, August 05, 2025
Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform
Posted On Tuesday, August 05, 2025
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
Posted On Tuesday, August 05, 2025
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
Posted On Tuesday, August 05, 2025
Galecto Reports Second Quarter 2025 Operating and Financial Results
Posted On Tuesday, August 05, 2025
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
Posted On Tuesday, August 05, 2025
Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights
Posted On Tuesday, August 05, 2025
Supernus Announces Second Quarter 2025 Financial Results
Posted On Tuesday, August 05, 2025
Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
Posted On Tuesday, August 05, 2025
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
Posted On Tuesday, August 05, 2025
Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum
Posted On Tuesday, August 05, 2025
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12
Posted On Tuesday, August 05, 2025
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
Posted On Tuesday, August 05, 2025
Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Posted On Tuesday, August 05, 2025
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Posted On Tuesday, August 05, 2025
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
Posted On Tuesday, August 05, 2025
BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates
Posted On Tuesday, August 05, 2025

Print